Navigation Links
Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting
Date:5/7/2008

NEW BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- Johnson & Johnson will provide a pre-recorded webcast for financial analysts on Friday, May 9 at 4:00 p.m. (Eastern Time) to coincide with the American Pain Society's (APS) annual meeting in Tampa, Fla. Phase 3 clinical data presentations on investigational tapentadol immediate release (IR), a novel centrally acting oral analgesic, will be presented for the first time at APS.

A pre-recorded Webcast, with the lead tapentadol researchers, will be made available concurrent to the data presentations being made during the poster session at APS. Pre-registration is not required to view the webcast/podcast.

The presentation will provide an overview on tapentadol IR and review data from the following clinical posters:
-- Efficacy of Tapentadol Immediate Release in Patients With Pain After

Bunionectomy

-- Analgesic Efficacy of Tapentadol Immediate Release in Patients With

Pain From End-Stage Joint Disease

-- Tapentadol Immediate Release is Associated With Improved

Gastrointestinal Tolerability Compared With Oxycodone Immediate Release

Over 90 Days in Patients With Lower Back or Osteoarthritis Pain

The webcast/podcast and replay can be accessed by clicking on "Webcasts/Presentations" in the Investor Relations section of the Company's website at http://www.jnj.com.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Steroids Provide No Survival Benefit for Children With Bacterial Meningitis
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. Gene Therapy Provides Vision to People who Were Nearly Blind
5. Arpida Provides Further Comments on the Pivotal Phase III Trials
6. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
7. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
8. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
9. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
10. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
11. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... CarpalAID is a revolutionary new product that relieves painful carpal tunnel ... syndrome affects more than 8 million people a year. Women suffer ... common methods of treating CTS are painful surgery, the use of ... ... is a clear patch worn on the palm of the hand. ...
(Date:7/11/2017)... -- The global market for liquid biopsy diagnostic and monitoring ... 2016.  Although in early stages, the global market has ... a result of the gradual shift towards personalized medicine ... a significant number of new liquid biopsy tests that ... to guide treatment decisions. ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... ... (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins Will, Newcomb ... the structural topping out of the new Destination Medical Building located at ...
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... ... under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted ... of California Department of Health Care Services, will facilitate the development of a ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... The International ... the life-altering neurological condition called essential tremor (ET). The seminar will take place on ... Rockside Woods Blvd., Independence, OH. The program will run from 9 a.m. to 12 ...
(Date:7/24/2017)... ... July 24, 2017 , ... Independence Blue Cross (Independence) ... an Innovation Collaboration program, have signed a five-year agreement that will marshal resources ... care members and patients receive. The agreement also signifies Jefferson Health officially joining ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
Breaking Medicine News(10 mins):